425 related articles for article (PubMed ID: 19826036)
1. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling.
Yang C; Sudderth J; Dang T; Bachoo RM; McDonald JG; DeBerardinis RJ
Cancer Res; 2009 Oct; 69(20):7986-93. PubMed ID: 19826036
[TBL] [Abstract][Full Text] [Related]
2. Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma.
Tardito S; Oudin A; Ahmed SU; Fack F; Keunen O; Zheng L; Miletic H; Sakariassen PØ; Weinstock A; Wagner A; Lindsay SL; Hock AK; Barnett SC; Ruppin E; Mørkve SH; Lund-Johansen M; Chalmers AJ; Bjerkvig R; Niclou SP; Gottlieb E
Nat Cell Biol; 2015 Dec; 17(12):1556-68. PubMed ID: 26595383
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Imaging Detects Low Levels of Glycolytic Activity That Vary with Levels of c-Myc Expression in Patient-Derived Xenograft Models of Glioblastoma.
Mair R; Wright AJ; Ros S; Hu DE; Booth T; Kreis F; Rao J; Watts C; Brindle KM
Cancer Res; 2018 Sep; 78(18):5408-5418. PubMed ID: 30054337
[No Abstract] [Full Text] [Related]
4. MYC sensitises cells to apoptosis by driving energetic demand.
Edwards-Hicks J; Su H; Mangolini M; Yoneten KK; Wills J; Rodriguez-Blanco G; Young C; Cho K; Barker H; Muir M; Guerrieri AN; Li XF; White R; Manasterski P; Mandrou E; Wills K; Chen J; Abraham E; Sateri K; Qian BZ; Bankhead P; Arends M; Gammoh N; von Kriegsheim A; Patti GJ; Sims AH; Acosta JC; Brunton V; Kranc KR; Christophorou M; Pearce EL; Ringshausen I; Finch AJ
Nat Commun; 2022 Aug; 13(1):4674. PubMed ID: 35945217
[TBL] [Abstract][Full Text] [Related]
5. Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma.
Trejo-Solis C; Silva-Adaya D; Serrano-García N; Magaña-Maldonado R; Jimenez-Farfan D; Ferreira-Guerrero E; Cruz-Salgado A; Castillo-Rodriguez RA
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139462
[TBL] [Abstract][Full Text] [Related]
6. Arecoline promotes Akt-c-Myc-driven aerobic glycolysis in esophageal epithelial cells.
Han S; Chen Y; Huang Y; Jin L; Ma Y
Environ Toxicol; 2024 May; 39(5):2794-2802. PubMed ID: 38282581
[TBL] [Abstract][Full Text] [Related]
7. Glutamine addiction promotes glucose oxidation in triple-negative breast cancer.
Quek LE; van Geldermalsen M; Guan YF; Wahi K; Mayoh C; Balaban S; Pang A; Wang Q; Cowley MJ; Brown KK; Turner N; Hoy AJ; Holst J
Oncogene; 2022 Aug; 41(34):4066-4078. PubMed ID: 35851845
[TBL] [Abstract][Full Text] [Related]
8. USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer.
Li M; Yu J; Ju L; Wang Y; Jin W; Zhang R; Xiang W; Ji M; Du W; Wang G; Qian K; Zhang Y; Xiao Y; Wang X
Cell Death Dis; 2024 Jan; 15(1):44. PubMed ID: 38218970
[TBL] [Abstract][Full Text] [Related]
9. The
Dejure FR; Royla N; Herold S; Kalb J; Walz S; Ade CP; Mastrobuoni G; Vanselow JT; Schlosser A; Wolf E; Kempa S; Eilers M
EMBO J; 2017 Jul; 36(13):1854-1868. PubMed ID: 28408437
[TBL] [Abstract][Full Text] [Related]
10. Investigations into the Signaling Pathways Involving Glucose-Stimulated Zinc Secretion (GSZS) from Prostate Epithelial Cells In Vitro and In Vivo.
Parrott D; Suh EH; Khalighinejad P; Jordan VC; Arreola I; Lo ST; Sherry AD
Mol Imaging Biol; 2023 Oct; 25(5):935-943. PubMed ID: 37097498
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells.
Trejo-Solís C; Castillo-Rodríguez RA; Serrano-García N; Silva-Adaya D; Vargas-Cruz S; Chávez-Cortéz EG; Gallardo-Pérez JC; Zavala-Vega S; Cruz-Salgado A; Magaña-Maldonado R
Metabolites; 2024 Apr; 14(5):. PubMed ID: 38786726
[TBL] [Abstract][Full Text] [Related]
12. Formyl-peptide receptor 2 signalling triggers aerobic metabolism of glucose through Nox2-dependent modulation of pyruvate dehydrogenase activity.
Cimmino TP; Pagano E; Stornaiuolo M; Esposito G; Ammendola R; Cattaneo F
Open Biol; 2023 Oct; 13(10):230336. PubMed ID: 37875162
[TBL] [Abstract][Full Text] [Related]
13. A Role for p53 in the Adaptation to Glutamine Starvation through the Expression of SLC1A3.
Tajan M; Hock AK; Blagih J; Robertson NA; Labuschagne CF; Kruiswijk F; Humpton TJ; Adams PD; Vousden KH
Cell Metab; 2018 Nov; 28(5):721-736.e6. PubMed ID: 30122553
[TBL] [Abstract][Full Text] [Related]
14. Glutamine-derived 2-hydroxyglutarate is associated with disease progression in plasma cell malignancies.
Gonsalves WI; Ramakrishnan V; Hitosugi T; Ghosh T; Jevremovic D; Dutta T; Sakrikar D; Petterson XM; Wellik L; Kumar SK; Nair KS
JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321378
[TBL] [Abstract][Full Text] [Related]
15. Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer.
Zhang GQ; Xi C; Ju NT; Shen CT; Qiu ZL; Song HJ; Luo QY
J Endocrinol Invest; 2024 Feb; ():. PubMed ID: 38386265
[TBL] [Abstract][Full Text] [Related]
16. Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism.
Fendt SM; Bell EL; Keibler MA; Davidson SM; Wirth GJ; Fiske B; Mayers JR; Schwab M; Bellinger G; Csibi A; Patnaik A; Blouin MJ; Cantley LC; Guarente L; Blenis J; Pollak MN; Olumi AF; Vander Heiden MG; Stephanopoulos G
Cancer Res; 2013 Jul; 73(14):4429-38. PubMed ID: 23687346
[TBL] [Abstract][Full Text] [Related]
17. From Krebs to clinic: glutamine metabolism to cancer therapy.
Altman BJ; Stine ZE; Dang CV
Nat Rev Cancer; 2016 Oct; 16(10):619-34. PubMed ID: 27492215
[TBL] [Abstract][Full Text] [Related]
18. Xanthohumol suppresses glioblastoma via modulation of Hexokinase 2 -mediated glycolysis.
Yuan J; Peng G; Xiao G; Yang Z; Huang J; Liu Q; Yang Z; Liu D
J Cancer; 2020; 11(14):4047-4058. PubMed ID: 32368287
[TBL] [Abstract][Full Text] [Related]
19. Glutamine addiction and therapeutic strategies in pancreatic cancer.
Ren LL; Mao T; Meng P; Zhang L; Wei HY; Tian ZB
World J Gastrointest Oncol; 2023 Nov; 15(11):1852-1863. PubMed ID: 38077649
[TBL] [Abstract][Full Text] [Related]
20. Key Roles of Glutamine Pathways in Reprogramming the Cancer Metabolism.
Michalak KP; Maćkowska-Kędziora A; Sobolewski B; Woźniak P
Oxid Med Cell Longev; 2015; 2015():964321. PubMed ID: 26583064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
